UNRESECTABLE CUTANEOUS MELANOMA
Clinical trials for UNRESECTABLE CUTANEOUS MELANOMA explained in plain language.
Never miss a new study
Get alerted when new UNRESECTABLE CUTANEOUS MELANOMA trials appear
Sign up with your email to follow new studies for UNRESECTABLE CUTANEOUS MELANOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Custom-Made vaccine targets tough cancers in early trial
⭐️ VACCINE ⭐️ Recruiting nowThis early-phase study is testing a personalized vaccine made from each patient's unique tumor mutations. The goal is to see if it is safe and can help the immune system fight advanced breast cancer, melanoma, and non-small cell lung cancer. About 25 adults whose cancers have spr…
Matched conditions: UNRESECTABLE CUTANEOUS MELANOMA
Phase: PHASE1 • Sponsor: Fred Hutchinson Cancer Center • Aim: ⭐️ VACCINE ⭐️
Last updated May 11, 2026 20:52 UTC
-
Morning may matter: new trial tests timing of melanoma treatment
Disease control Recruiting nowThis study is testing whether giving immunotherapy drugs (ipilimumab and nivolumab) in the morning works better than giving them later in the day for people with advanced melanoma that cannot be removed by surgery. About 99 adults with stage IV melanoma will be randomly assigned …
Matched conditions: UNRESECTABLE CUTANEOUS MELANOMA
Phase: PHASE2 • Sponsor: Emory University • Aim: Disease control
Last updated May 13, 2026 15:59 UTC
-
Cancer patients may soon get immunotherapy at home – no more long clinic trips!
Symptom relief Recruiting nowThis study looks at whether giving the cancer drug nivolumab as a shot at home is as good as getting it at the clinic. About 50 adults with various cancers will try both ways to see which they prefer and how it affects their quality of life. The goal is to reduce the time, cost, …
Matched conditions: UNRESECTABLE CUTANEOUS MELANOMA
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Symptom relief
Last updated May 17, 2026 03:08 UTC